Who owns CITIUS PHARMACEUTICALS INC COM?
- Ticker: CTXR
- CUSIP Number: 17322u306
Tip: Access positions for across all investors
Analyze quarterly positions in Citius Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Citius Pharmaceuticals stock
Who bought or sold CITIUS PHARMACEUTICALS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Heights Capital Management | 800k | $622k | 100% | Dec 2025 |
|
| Geode Capital Management | 246k | $222k | 93% | Mar 2026 |
|
| Vanguard Group | 199k | $155k | 20% | Dec 2025 |
|
| Vanguard Capital Management | 168k | $151k | 100% | Mar 2026 |
|
| XTX Topco | 107k | $83k | 573% | Dec 2025 |
|
| Susquehanna International | 81k | $63k | 14% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 78k | $70k | 100% | Mar 2026 |
|
| BlackRock | 70k | $63k | 0% | Mar 2026 |
|
| Hrt Financial | 60k | $54k | 100% | Mar 2026 |
|
| Asset Advisory Group | 59k | $53k | 100% | Mar 2026 |
|
| UBS Group | 55k | $50k | -28% | Mar 2026 |
|
| Jane Street | 46k | $42k | 159% | Mar 2026 |
|
| Northern Trust | 44k | $34k | 63% | Dec 2025 |
|
| Citadel Advisors | 29k | $26k | -57% | Mar 2026 |
|
| LPL Financial | 25k | $23k | 0% | Mar 2026 |
|
| State Street Corporation | 23k | $18k | 0% | Dec 2025 |
|
| Arkadios Wealth Advisors | 20k | $18k | 0% | Mar 2026 |
|
| Miller Financial Services | 14k | $13k | 100% | Mar 2026 |
|
| Two Sigma Investments | 13k | $12k | -78% | Mar 2026 |
|
| IFP Advisors | 7.1k | $6.4k | 0% | Mar 2026 |
|
| SBI Securities | 6.5k | $5.9k | 62% | Mar 2026 |
|
| Citigroup | 5.2k | $4.7k | 100% | Mar 2026 |
|
| Chelsea Counsel | 4.6k | $4.2k | 0% | Mar 2026 |
|
| Quent Capital | 4.3k | $3.8k | 361% | Mar 2026 |
|
| Tower Research Capital | 2.8k | $2.2k | 100% | Dec 2025 |
|
| Curio Wealth | 2.0k | $1.8k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 1.8k | $1.6k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 1.5k | $1.2k | 0% | Dec 2025 |
|
| Morgan Stanley | 1.4k | $1.2k | -33% | Mar 2026 |
|
| Ameritas Advisory Services | 1.0k | $900.000000 | 100% | Mar 2026 |
|
| Goss Wealth Management | 400.00 | $360.000000 | 0% | Mar 2026 |
|
| Assetmark | 372.00 | $334.986000 | 100% | Mar 2026 |
|
| Murphy & Mullick Capital Management Corp | 160.00 | $144.000000 | 0% | Mar 2026 |
|
| Princeton Global Asset Management | 160.00 | $144.000000 | 0% | Mar 2026 |
|
| Smallwood Wealth Investment Management | 120.00 | $108.000000 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 107.00 | $96.000400 | 0% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 80.00 | $72.000000 | 0% | Mar 2026 |
|
| Fairscale Capital | 42.00 | $38.001600 | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 8.00 | $8.000000 | 100% | Mar 2026 |
|
| Bogart Wealth | 4.00 | $4.000000 | 100% | Mar 2026 |
|
Who sold out of Citius Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Securities | Dec 2025 | 29k | $22k |
| Scientech Research | Dec 2025 | 21k | $16k |
| Simplex Trading | Sep 2025 | 9.6k | $11k |
| Luminist Capital | Dec 2025 | 435.00 | $337.995000 |
| Jpmorgan Chase & Co | Sep 2025 | 120.00 | $149.004000 |
| SRS Capital Advisors | Dec 2025 | 84.00 | $64.999200 |
| Harbour Investments | Dec 2025 | 50.00 | $39.000000 |
| Wells Fargo & Company | Dec 2025 | 40.00 | $31.000000 |
| TD Waterhouse Canada | Dec 2025 | 4.00 | $3.000000 |